Daxor Price to Free Cash Flow Ratio 2010-2011 | DXR

Historical price to free cash flow ratio values for Daxor (DXR) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Daxor Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2024-06-28 9.32 0.00
2011-12-31 8.64 $-1.57 0.00
2011-09-30 9.93 $-1.78 0.00
2011-06-30 9.57 $-1.91 0.00
2011-03-31 9.51 $-1.85 0.00
2010-12-31 8.58 $-1.40 0.00
2010-09-30 8.00 $-1.25 0.00
2010-06-30 8.55 $-1.17 0.00
2010-03-31 9.50 $-1.27 0.00
2009-12-31 10.15 $-1.72 0.00
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.046B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.643B 10.07
Quest Diagnostics (DGX) United States $15.257B 15.77
DaVita (DVA) United States $12.405B 15.41
Encompass Health (EHC) United States $8.645B 22.13
Chemed (CHE) United States $8.250B 25.57
Elanco Animal Health (ELAN) United States $7.052B 18.30
Option Care Health (OPCH) United States $4.858B 18.39
RadNet (RDNT) United States $4.352B 90.61
Amedisys (AMED) United States $3.038B 21.52
Astrana Health (ASTH) United States $2.284B 30.89
Addus HomeCare (ADUS) United States $1.870B 26.75
LifeStance Health (LFST) United States $1.866B 0.00
U.S Physical Therapy (USPH) United States $1.403B 37.55
Pennant (PNTG) United States $0.682B 36.05
Aveanna Healthcare Holdings (AVAH) United States $0.492B 0.00
Atai Life Sciences (ATAI) Germany $0.221B 0.00
ATI Physical Therapy (ATIP) United States $0.020B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Novo Integrated Sciences (NVOS) United States $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00